Search filters

List of works by Paul Haluska

A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer.

scientific article published on 18 November 2015

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

scientific article published on 14 November 2017

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

scientific article published on 10 July 2014

A role for the amino terminus of human topoisomerase I ⬇️

scientific article published on 01 January 1998

Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

scientific article published on 10 January 2017

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

scientific article published on 12 January 2020

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

scientific article

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

scientific article published on April 2017

Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft

scientific article published on 11 May 2015

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

scientific article published on 15 October 2013

Epithelial ovarian cancer experimental models.

scientific article published on 12 August 2013

Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts

article

High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.

scientific article published on 02 March 2016

High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecin ⬇️

scientific article published on April 10, 1998

Hormone response in ovarian cancer: time to reconsider as a clinical target?

scientific article published on 9 November 2012

IGFBP Ratio Confers Resistance to IGF Targeting and Correlates with Increased Invasion and Poor Outcome in Breast Tumors ⬇️

scientific article published on January 27, 2012

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.

scientific article published on 07 September 2016

Insulin-like growth factor pathway ⬇️

scientific article published on 01 December 2010

Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen ⬇️

scientific article published on April 1, 1998

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study

scientific article

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

scientific article

Patient-derived xenograft models in gynecologic malignancies

scientific article

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment

scientific article

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

scientific article published on 21 November 2019

Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.

scientific article published on 28 April 2017

Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors

scientific article

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

scientific article

Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma ⬇️

scientific article published on April 22, 2011

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts

scientific article

Quantifying insulin receptor isoform expression in FFPE breast tumors ⬇️

scientific article published on April 30, 2012

Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions

scientific article published on June 1, 2011

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

scientific article

The Insulin-Like Growth Factor System in Cancer ⬇️

scientific article published on June 1, 2012

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

scientific article published on 07 January 2014

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

scientific article (publication date: 2015)

Paulina is supported by:

About Paulina

Help